rs41295899

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_003227.4(TFR2):​c.1449C>T​(p.Ser483Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0011 in 1,602,130 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0062 ( 9 hom., cov: 31)
Exomes 𝑓: 0.00059 ( 5 hom. )

Consequence

TFR2
NM_003227.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.334

Publications

1 publications found
Variant links:
Genes affected
TFR2 (HGNC:11762): (transferrin receptor 2) This gene encodes a single-pass type II membrane protein, which is a member of the transferrin receptor-like family. This protein mediates cellular uptake of transferrin-bound iron, and may be involved in iron metabolism, hepatocyte function and erythrocyte differentiation. Mutations in this gene have been associated with hereditary hemochromatosis type III. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, May 2011]
TFR2 Gene-Disease associations (from GenCC):
  • hemochromatosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 7-100628248-G-A is Benign according to our data. Variant chr7-100628248-G-A is described in ClinVar as Benign. ClinVar VariationId is 258986.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.334 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00615 (900/146274) while in subpopulation AFR AF = 0.0208 (820/39462). AF 95% confidence interval is 0.0196. There are 9 homozygotes in GnomAd4. There are 430 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TFR2NM_003227.4 linkc.1449C>T p.Ser483Ser synonymous_variant Exon 11 of 18 ENST00000223051.8 NP_003218.2
TFR2NM_001206855.3 linkc.936C>T p.Ser312Ser synonymous_variant Exon 8 of 15 NP_001193784.1
LOC124901709XR_007060454.1 linkn.434-2908G>A intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TFR2ENST00000223051.8 linkc.1449C>T p.Ser483Ser synonymous_variant Exon 11 of 18 1 NM_003227.4 ENSP00000223051.3

Frequencies

GnomAD3 genomes
AF:
0.00615
AC:
899
AN:
146182
Hom.:
9
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0208
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00396
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00325
Gnomad NFE
AF:
0.0000894
Gnomad OTH
AF:
0.00845
GnomAD2 exomes
AF:
0.00147
AC:
369
AN:
251390
AF XY:
0.00102
show subpopulations
Gnomad AFR exome
AF:
0.0198
Gnomad AMR exome
AF:
0.000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000593
AC:
864
AN:
1455856
Hom.:
5
Cov.:
39
AF XY:
0.000507
AC XY:
367
AN XY:
724226
show subpopulations
African (AFR)
AF:
0.0209
AC:
696
AN:
33296
American (AMR)
AF:
0.00117
AC:
52
AN:
44518
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25904
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39310
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86200
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52814
Middle Eastern (MID)
AF:
0.000699
AC:
4
AN:
5724
European-Non Finnish (NFE)
AF:
0.0000307
AC:
34
AN:
1108112
Other (OTH)
AF:
0.00130
AC:
78
AN:
59978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
56
112
167
223
279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00615
AC:
900
AN:
146274
Hom.:
9
Cov.:
31
AF XY:
0.00607
AC XY:
430
AN XY:
70866
show subpopulations
African (AFR)
AF:
0.0208
AC:
820
AN:
39462
American (AMR)
AF:
0.00395
AC:
56
AN:
14162
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3434
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4796
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4546
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9556
Middle Eastern (MID)
AF:
0.00350
AC:
1
AN:
286
European-Non Finnish (NFE)
AF:
0.0000894
AC:
6
AN:
67106
Other (OTH)
AF:
0.00837
AC:
17
AN:
2030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
42
84
127
169
211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00296
Hom.:
4
Bravo
AF:
0.00644
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hemochromatosis type 3 Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary hemochromatosis Benign:1
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.61
CADD
Benign
1.3
DANN
Benign
0.86
PhyloP100
-0.33
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41295899; hg19: chr7-100225871; COSMIC: COSV56153937; COSMIC: COSV56153937; API